DrugPatentWatch Database Preview
Profile for Japan Patent: 2004534047
US Patent Family Members and Approved Drugs for Japan Patent: 2004534047
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | May 23, 2022 | Pfizer Inc | XELJANZ XR | tofacitinib citrate |
➤ Try a Free Trial | May 23, 2022 | Pf Prism Cv | XELJANZ | tofacitinib citrate |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |